In this study, we first explored the relationship between E2F4 expression and clinical phenotype in HNSCC, the role of E2F4 in the progression of HNSCC, especially as a prognostic factor of HNSCC, and its importance as a potential biomarker for the prognosis of HNSCC patients. This evidence concerns the gene E2F4 and head and neck squamous cell carcinoma.